Cancer BiologybioRxivPreprint
Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma
Sampurna Chatterjee, Pragya Kumar, Ashwin Srinivasan Kumar…·Rakesh K. Jain
This study identifies SPHK2 as a therapeutic target in G3MB, showing that its inhibition restores anti-tumor immunity and improves survival in mouse models, with enhanced effects when combined with radiation.
DOI 10.64898/2026.08.12.744521